H.R. 3401 · 108th Congress
Generic Drugs Access Act of 2003
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 108th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
PalloneSponsorNo cosponsors.
Generic Drugs Access Act of 2003 - Amends the Federal Food, Drug, and Cosmetic Act with respect to new drug applications to direct the Secretary of Health and Human Services to include in an application approval a finding about whether the approved (generic) drug is the therapeutic equivalent of the listed drug involved.
What it does: CRS summary · Introduced in House · Oct 29, 2003
Generic Drugs Access Act of 2003 - Amends the Federal Food, Drug, and Cosmetic Act with respect to new drug applications to direct the Secretary of Health and Human Services to include in an application approval a finding about whether the approved (generic) drug is the therapeutic equivalent of the listed drug involved.
Prohibits a State or its political subdivision from establishing or continuing any requirement that does not conform to the therapeutic equivalence requirement of this Act.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Generic Drugs Access Act of 2003
Latest action (Nov 14, 2003): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Oct 29, 2003
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.